NSC |
Compound |
Enrichment |
Correlation |
NSC 678925 |
1-Phenazinecarboxamide, N-[2-(dimethylamino)ethyl]- 9-fluoro-, monohydrochloride |
0.00131875202369342 |
0.33812045 |
NSC 698959 |
Null |
0.00160168059169488 |
0.47328812 |
NSC 703141 |
Null |
0.00160168059169488 |
0.1795418 |
NSC 711611 |
Null |
0.00160168059169488 |
0.40378423 |
NSC 725191 |
1,6-bis[(1S,4R,5R,8R,12R,13S)-1,5-dimethyl-10-(trifluorometh yl)-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexade c-9-en-9-yl]-3-hexene-1,6-diol |
0.00160168059169488 |
0.42446017 |
NSC 735540 |
5-fluoro-N-(2-methyl-3-oxo-8-phenyl-1-thia-4-azaspiro[4.5]de c-4-yl)-3-phenyl-1H-indole-2-carboxamide |
0.00160168059169488 |
0.59381654 |
NSC 740385 |
7-fluoro-2-benzoyl-3-trifluoromethylquioxaline 1,4-dioxide |
0.00160168059169488 |
0.59274236 |
NSC 128571 |
Ethanesulfonic acid, compd. with 2-chloro-5-[4-[2-chloro-4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) (8CI) |
0.0016016805916949 |
0.6372005 |
NSC 169774 |
Bromocriptine methanesulfonate |
0.0016016805916949 |
0.40127479 |
NSC 22348 |
1H-Naphth[2,3-d]imidazole-4,9-dione, 1-(p-bromophenyl)- 2-methyl- |
0.0016016805916949 |
0.57424675 |